Advertisement
Screener

Filana Therapeutics, Inc. (FLNA) Other Non-Current Assets

2.8 / 5 stars · 68/120 Roast Me

Filana Therapeutics, Inc. Other Non-Current Assets

Filana Therapeutics, Inc. (FLNA) had Other Non-Current Assets of $399.00 thousand as of 2021-12-31, per its 10-K filed 2023-02-28.

Discontinued › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:OtherAssetsNoncurrent · last filed 2023-02-28

  • 2021-12-31: Other Assets, Noncurrent $399.00K.
  • 2021-09-30: Other Assets, Noncurrent $199.00K.
  • 2021-06-30: Other Assets, Noncurrent $1.42M.
  • 2019-09-30: Other Assets, Noncurrent $12.00K.
Period endOther Assets, Noncurrent
2021-12-31$399.00K
10-K · filed 2023-02-28
2021-09-30$199.00K
10-Q · filed 2021-11-15
2021-06-30$1.42M
10-Q · filed 2021-08-04
2019-09-30$12.00K
10-Q · filed 2019-10-29
2019-06-30$12.00K
10-Q · filed 2019-08-12
2019-03-31$12.00K
10-Q · filed 2019-05-02
2018-12-31$12.00K
10-K · filed 2020-03-26
2018-09-30$12.00K
10-Q · filed 2018-10-30
2018-06-30$12.00K
10-Q · filed 2018-07-26
2018-03-31$30.00K
10-Q · filed 2018-05-09
2017-12-31$12.00K
10-K · filed 2019-03-29
2016-09-30$12.00K
10-Q · filed 2016-10-26
2016-06-30$12.00K
10-Q · filed 2016-07-19
2016-03-31$12.00K
10-Q · filed 2016-05-05
2015-12-31$12.00K
10-K · filed 2017-03-07
2015-09-30$12.00K
10-Q · filed 2015-11-09
2015-06-30$12.00K
10-Q · filed 2015-07-23
2015-03-31$12.00K
10-Q · filed 2015-05-08
2014-12-31$12.00K
10-K · filed 2016-03-03
2014-09-30$12.00K
10-Q · filed 2014-11-05
2014-06-30$12.00K
10-Q · filed 2014-08-06
2013-09-30$340.00K
10-Q · filed 2013-11-01
2013-06-30$352.00K
10-Q · filed 2013-08-01
2013-03-31$352.00K
10-Q · filed 2013-04-24
2012-12-31$352.00K
10-K · filed 2014-02-05
2012-09-30$352.00K
10-Q · filed 2012-11-09
2012-06-30$351.00K
10-Q · filed 2012-08-02
2012-03-31$352.00K
10-Q · filed 2012-05-08
2011-12-31$352.00K
10-K · filed 2013-02-08
2011-09-30$351.00K
10-Q · filed 2011-11-03
2011-06-30$437.00K
10-Q · filed 2011-08-04
2010-12-31$426.00K
10-K · filed 2012-02-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
PMGC Holdings Inc. (ELAB)United States$0.037B
Celularity Inc (CELU)United States$0.038B-0.34
BriaCell Therapeutics Corp. (BCTX)$0.037B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Incannex Healthcare Inc. (IXHL)$0.040B-22.32